401 related articles for article (PubMed ID: 16397213)
21. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A
Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962
[TBL] [Abstract][Full Text] [Related]
22. Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.
Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Scarpi E; Falcini F; Strada M; Morini N; Naldoni C; Amadori D; Calistri D
Breast Cancer Res Treat; 2008 Nov; 112(2):343-9. PubMed ID: 18092194
[TBL] [Abstract][Full Text] [Related]
23. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiñski J; Scott RJ; Hamann U
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):270-5. PubMed ID: 17301259
[TBL] [Abstract][Full Text] [Related]
24. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG
Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204
[TBL] [Abstract][Full Text] [Related]
25. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation.
Annab LA; Terry L; Cable PL; Brady J; Stampfer MR; Barrett JC; Afshari CA
Gynecol Oncol; 2000 Apr; 77(1):121-8. PubMed ID: 10739701
[TBL] [Abstract][Full Text] [Related]
27. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
28. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
29. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
[TBL] [Abstract][Full Text] [Related]
31. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.
Orban TI; Olah E
Biochem Biophys Res Commun; 2001 Jan; 280(1):32-8. PubMed ID: 11162473
[TBL] [Abstract][Full Text] [Related]
32. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
[TBL] [Abstract][Full Text] [Related]
33. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Egeli U; Cecener G; Tunca B; Tasdelen I
Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
[TBL] [Abstract][Full Text] [Related]
34. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression.
Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK
Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214
[TBL] [Abstract][Full Text] [Related]
35. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
King TA; Li W; Brogi E; Yee CJ; Gemignani ML; Olvera N; Levine DA; Norton L; Robson ME; Offit K; Borgen PI; Boyd J
Ann Surg Oncol; 2007 Sep; 14(9):2510-8. PubMed ID: 17597348
[TBL] [Abstract][Full Text] [Related]
36. High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Torres D; Rashid MU; Gil F; Umana A; Ramelli G; Robledo JF; Tawil M; Torregrosa L; Briceno I; Hamann U
Breast Cancer Res Treat; 2007 Jun; 103(2):225-32. PubMed ID: 17080309
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer.
Han SH; Lee KR; Lee DG; Kim BY; Lee KE; Chung WS
Clin Genet; 2006 Dec; 70(6):496-501. PubMed ID: 17100994
[TBL] [Abstract][Full Text] [Related]
38. Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene.
Claes K; Vandesompele J; Poppe B; Dahan K; Coene I; De Paepe A; Messiaen L
Oncogene; 2002 Jun; 21(26):4171-5. PubMed ID: 12037674
[TBL] [Abstract][Full Text] [Related]
39. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
Gough CA; Gojobori T; Imanishi T
Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
[TBL] [Abstract][Full Text] [Related]
40. [Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].
Meng J; Shi YR; Niu RF; Fu L
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):79-82. PubMed ID: 19489266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
